Affinity Chromatography in Bioprocess
Affinity Chromatography in Bioprocess
Affinity Chromatography in Bioprocess
1
B.Pascal, K.E. George, F. Wen Jian, B. Wolfgang, Affinity Chromatography: Methods and Protocols.
Affinity chromatography effectively binds specific solutes by taking advantages on
the solutes biological interactions. Antibodies, antigens, or dyes are conjugated to polymer
resins for the purpose of binding specific solutes from a mixture. For example, an antibody
could be raised against a target protein. The antibody then captures the solute out of the
mixture, and the impurities flow through the column. The solute can be recovered by
changing the pH, increasing the salt concentration, or adding displacer, that is, a molecule
that also has some affinity for the antibody, or other binding agent (affinity ligand) on the
stationary phase.
Other examples such as isolation of proteins, it is made possible by using the
special interactions of enzyme-ligand, enzyme-cofactor, receptor-agonist (antagonist). In
each case, one member of any of these pairs may be immobilized to a resin to isolate the
desired partner. Affinity chromatography is commonly coupled with cloning techniques to
synthesize the target molecule with an “epitope” or recognition sequence that can be
captured by the affinity ligand.
Below are a few descriptions on application of affinity chromatography:
Immunoglobulin or antibody is a protein used by the immune system for the purpose
of defence against foreign substances such as bacteria and or viruses. The antibody
recognizes the antigen. The antibody contains a paratope that is specific for one antigen,
thus, aids in high attraction between the antibody and antigen. So, the antibody can tag a
microbes or infected cell that may attack immune system.
Due to the variety of antibody-antigen interactions has created many uses for
antibodies and antibody fragments. They are used for therapeutic and diagnostic
applications as well as for immunochemical techniques within general research. The use of
recombinant technology has greatly expanded our ability to manipulate the characteristics of
these molecules to our advantage. The potential exists to create an infinite number of
combinations between immunoglobulin and immunoglobulin fragments with tags and other
selected proteins. A significant advantage for the purification of antibodies and their
fragments is that a great deal of information is available about the properties of the target
molecule and the major contaminants, no matter whether the molecule is in its a native state
or has been genetically engineered and no matter what the source material.